TETANUS

IN acute rheumatic fever it is a well-known fac t th at joint symptoms and pyrexia in the great majority of cases are controlled by th e adequate oral administration of salicylates. However, it is extremely doubtful whether salicylates influence the course of rheumatic carditis. It would appear, therefore, that any drug that could control all the features of rheumatic fever would be a most valuabl e therapeutic agent. From 'recent work it would seem likely that cortisone is such an agent, although no conclusive evidence or long-term results are available to indicate that it does prevent cardiac damage.